CHRISTOPHER GESSEL: Open Payments
NPI 1851732655 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,486 in 247 payments from 24 companies in 2025. Trend: 2023 $2,457 · 2024 $10,390 · 2025 $9,486
Food & beverage: $5,096Consulting: $2,288Travel & lodging: $1,868Education: $234
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 16 | $3,312 |
| Inspire Medical Systems, Inc. | 41 | $1,814 |
| AstraZeneca Pharmaceuticals LP | 24 | $737 |
| GlaxoSmithKline, LLC. | 26 | $517 |
| United Therapeutics Corporation | 12 | $346 |
| GENZYME CORPORATION | 10 | $311 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $274 |
| Viatris Specialty LLC | 14 | $249 |
| Axsome Therapeutics, Inc. | 18 | $229 |
| Merck Sharp & Dohme LLC | 9 | $216 |
Products named: DUPIXENT, INSPIRE, FASENRA, NUCALA, Adempas, YUPELRI, Sunosi, WINREVAIR.
Industry payments across UT — which companies pay providers there.
